Efficacy of Systane Ultra in Post Menopausal Women With Dry Eye

To evaluate the efficacy of Systane Ultra in post menopausal women with dry eye.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post Menopausal Dry Eye Subjects Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Post-menopausal (menses ceased more than 12 months prior to the start of the study).
Diagnosed for dry eye

Exclusion criteria

History of Sjögren's Syndrome or evidence of chronic dry eye syndrome. Confirmed autoimmune connective tissue diseases such as rheumatoid arthritis, fibromyalgia or scleroderma.
Active and severe blepharitis, rosacea and associated ocular sequelae.
Has any significant eyelid abnormality affecting lid function.

Treatment and study plan

Systane Ultra Lubricant Eye Drops

Other

1 to 2 drops in each eye 4 times per day for 30 days

Sensitive Eyes Eye Drops (Bausch & Lomb)

Other

1 to 2 drops in each eye 4 times per day for 30 days

Primary outcomes

Reduction in corneal staining

Time frame: 30 days

Secondary outcomes

Patient acceptability / comfort

Time frame: 30 days

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start: 2010
Primary completion: 2010
First posted: Apr 19, 2010
Registry last updated: Nov 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed